These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 7071608)
1. The cardiotoxicity of anticancer agents. Von Hoff DD; Rozencweig M; Piccart M Semin Oncol; 1982 Mar; 9(1):23-33. PubMed ID: 7071608 [TBL] [Abstract][Full Text] [Related]
2. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology]. Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619 [TBL] [Abstract][Full Text] [Related]
3. The cardiotoxicity of adriamycin and daunomycin in children. Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124 [TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Bristow MR; Billingham ME; Mason JW; Daniels JR Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861 [TBL] [Abstract][Full Text] [Related]
6. Exposure to anthracyclines during childhood causes cardiac injury. Lipshultz SE Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284 [TBL] [Abstract][Full Text] [Related]
7. [MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)]. Saganelidze K; Kavtaradze N Georgian Med News; 2018 May; (278):87-93. PubMed ID: 29905551 [TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of cardiotoxicity induced by anthracyclines. Elliott P Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283 [TBL] [Abstract][Full Text] [Related]
9. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases]. Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199 [No Abstract] [Full Text] [Related]
13. Preliminary testing of anthracycline-induced cardiotoxicity in children. Pejcic L; Vasic K J BUON; 2017; 22(6):1611-1612. PubMed ID: 29332369 [No Abstract] [Full Text] [Related]
14. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group. Seymour L; Bramwell V; Moran LA Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762 [TBL] [Abstract][Full Text] [Related]
16. Anticancer agents and cardiotoxicity. Ng R; Better N; Green MD Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms and Genetic Susceptibility of Chemotherapy-Induced Cardiotoxicity in Patients With Breast Cancer. Mihalcea DJ; Florescu M; Vinereanu D Am J Ther; 2017; 24(1):e3-e11. PubMed ID: 27145188 [TBL] [Abstract][Full Text] [Related]
18. Cardiac complications in cancer treatment - A review. Li X; Liu M; Sun R; Zeng Y; Chen S; Zhang P Hellenic J Cardiol; 2017; 58(3):190-193. PubMed ID: 28011332 [TBL] [Abstract][Full Text] [Related]
19. [Heart pathology of extracardiac origin. VII. Heart and neoplasms]. Calzas J; Lianes P; Cortés-Funes H Rev Esp Cardiol; 1998 Apr; 51(4):314-31. PubMed ID: 9608805 [TBL] [Abstract][Full Text] [Related]